Condition: Angina · Stable Ischemic Heart Disease · Sponsor: Yale University
To establish the effectiveness and tolerability of standard of care anti-anginal treatment (beta-blocker and calcium channel blocker medications) in older adults with symptomatic Stable Ischemic Heart Disease (SIHD) and multiple chronic conditions (MCC).
This description comes directly from the study's public registry record.
Michael Nanna, MD · (888) 683-0865 · livebetter-trial@yale.edu
Always discuss trial participation with your own doctor first.
| Yale School of Medicine | New Haven, Connecticut, United States | Recruiting |
| Wellstar Research Institute | Marietta, Georgia, United States | Recruiting |
| Cook County Health | Chicago, Illinois, United States | Recruiting |
| Brigham and Women's Hospital | Boston, Massachusetts, United States | Recruiting |
| Mt. Sinai Health System | New York, New York, United States | Recruiting |
| NYC Health and Hospitals, Harlem Hospital | New York, New York, United States | Not Yet Recruiting |
| Nirvana Integrative Medicine | New York, New York, United States | Recruiting |
| Duke University, School of Medicine | Durham, North Carolina, United States | Recruiting |
| Cleveland Clinic | Cleveland, Ohio, United States | Not Yet Recruiting |
| Inova Health Care Services | Fairfax, Virginia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05786417